Mr. President, on January 8 of this year, I requested the Government Accountability Office to conduct followup tests of our Nation's airport security screening procedures. Investigators attempted to smuggle bomb-making materials past…

Mr. President, so far during the 111th Congress, the Finance Committee, of which I serve as the ranking Republican member, has held over 50 hearings. At those hearings, around 200 witnesses offered their testimony and answered members'…

Mr. President, Congress meets in the District of Columbia. The District of Columbia is an island surrounded by reality. Only in the District of Columbia could you get away with telling the people if you like what you have you can keep it…

Mr. President, very soon, the Senate will be asked to vote on the motion to invoke cloture on the majority leader's motion to proceed to a bill that is mislabeled the ``Creating American Jobs and Ending Offshoring Act.'' The process for…

Mr. President, in a few minutes, the Senate will be voting on the motion to invoke cloture on the motion to proceed to a bill that has been mislabeled the ``Creating American Jobs and Ending Offshoring Act.'' The part of the bill that is…

I think we need to think about priorities.

Thank you again, Dr. Pavia.

I'm just thinking out loud here--is it FDA, or do we need to take something out of the FDA?

For all that we put on their plate.

And thank all of you for your testimonies, and for your work in this field, and your leadership in this field.

It's got great bipartisan support. It's being held up a little bit, but it's going to pass.

We know flu is here... we know there are a lot of other strains of flu out there.

I'd like to start thinking about it now, and looking at it.

The funding you're going to approve now is what kind of defense my kids and grandkids are going to have 5, 10 years from now, sir.

I mean, it's just--it's just very difficult to do that, okay? It's just difficult.

Is anthrax the major threat that we have that we should be worried about with regard to bioterrorism?

BARDA would be the purchaser, but this fund would be the investor.

I just think we're relying too much on the FDA.